Related Experiment Videos
Sympathetic skin response abnormalities in amyotrophic lateral sclerosis
C Dettmers1, D Fatepour, H Faust
1Neurologische Universitätsklinik, Bonn, Germany.
Muscle & Nerve
|September 1, 1993
Summary
Sympathetic skin response (SSR) testing revealed autonomic nervous system involvement in amyotrophic lateral sclerosis (ALS). Abnormal SSR findings in ALS patients suggest broader neurological impact beyond motor pathways.
Area of Science:
- Neurology
- Autonomic Neuroscience
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease primarily affecting motor neurons.
- Autonomic nervous system (ANS) dysfunction is increasingly recognized in ALS, but its extent requires further elucidation.
Purpose of the Study:
- To investigate the involvement of the autonomic nervous system in ALS patients using sympathetic skin response (SSR) testing.
- To compare SSR parameters between ALS patients, healthy controls, and muscular dystrophy patients.
Main Methods:
- Sympathetic skin response (SSR) was measured in 25 ALS patients, 22 age-matched healthy controls, and 6 muscular dystrophy patients.
- SSR latency and presence were analyzed and compared across the groups.
Main Results:
- SSR was intact in all healthy controls and muscular dystrophy patients.
- ALS patients exhibited significantly prolonged mean SSR latency compared to controls (2.29 ± 0.28 s vs. 2.13 ± 0.16 s, P < 0.05).
- SSR was absent in 40% of ALS patients (10 out of 25), indicating significant autonomic dysfunction.
Conclusions:
- The study demonstrates significant sympathetic skin response abnormalities in ALS patients.
- These findings suggest subclinical autonomic nervous system involvement in ALS, even in the absence of overt autonomic failure symptoms.
- SSR testing is a valuable tool for assessing ANS function in ALS and understanding the disease's complex pathophysiology.